In our February issue of Pharmaceutical Executive FEATURES Cover Story Beyond Boundaries: The Staying Power of Emerging Markets William Looney
Emerging country market-access experts from McKinsey & Co. sit down with Pharm Exec to discuss next-level strategies needed to build sustainable local businesses that maximize patient access to the product portfolio.
Supply Chain Pharma dot-gov: A New Business Model Richard Burcham
An advocate of business system automation in the global pharma supply chain offers a six-pronged approach to adapting to the realities of a new age of mounting regulation and customer expectations.
North America Canada’s Rx&D: A Fresh Start for a New Era William Looney Canada’s Rx&D, the industry’s oldest functioning trade association, recently changed its name—with a mission of bridging the many points of collaboration that drive the process of modern drugs, from discovery to market.
Interview Subhanu Saxena: Securing Cipla’s Future Julian Upton Pharm Exec interviews Subhanu Saxena, CEO of India pharma giant Cipla, who discusses the longtime emerging market champion’s strategic plans to raise its geographic profile and secure the company’s future in the US.
Morgan Moments: A Closer Reading of the 2016 JP Morgan Investor Conference William Looney
A closer reading of this year's JP Morgan investor conference identifies three areas where the insular, often maladroit tone of the industry-investor dialogue may be morphing to something more grounded in the larger societal context of healthcare.